Phillip E. Herrbrich

1.0k total citations
9 papers, 801 citations indexed

About

Phillip E. Herrbrich is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Phillip E. Herrbrich has authored 9 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Phillip E. Herrbrich's work include Mesenchymal stem cell research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cancer Cells and Metastasis (3 papers). Phillip E. Herrbrich is often cited by papers focused on Mesenchymal stem cell research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cancer Cells and Metastasis (3 papers). Phillip E. Herrbrich collaborates with scholars based in United States and United Kingdom. Phillip E. Herrbrich's co-authors include Jan A. Nolta, Louisa Wirthlin, David A. Hess, Todd E. Meyerrose, Timothy P. Craft, Michael H. Creer, Sarah Hohm, Ryan Lahey, William Eades and J. Chris Eagon and has published in prestigious journals such as Blood, Stem Cells and Molecular Therapy.

In The Last Decade

Phillip E. Herrbrich

9 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip E. Herrbrich United States 7 353 290 285 168 154 9 801
Rita Bussolari Italy 10 322 0.9× 233 0.8× 388 1.4× 158 0.9× 134 0.9× 13 784
Sarah Hohm United States 7 240 0.7× 182 0.6× 171 0.6× 128 0.8× 111 0.7× 10 571
Fabienne de Toni France 8 328 0.9× 236 0.8× 206 0.7× 143 0.9× 83 0.5× 12 651
Marcus Otte Germany 8 807 2.3× 339 1.2× 236 0.8× 96 0.6× 230 1.5× 10 1.2k
Lutz Peter Mueller Germany 14 342 1.0× 258 0.9× 383 1.3× 72 0.4× 99 0.6× 25 935
Alexey Bersenev United States 14 450 1.3× 230 0.8× 238 0.8× 228 1.4× 90 0.6× 24 838
Joshua Kellner United States 13 325 0.9× 131 0.5× 439 1.5× 202 1.2× 59 0.4× 23 812
K Kluge Germany 5 660 1.9× 236 0.8× 234 0.8× 77 0.5× 159 1.0× 7 902
Lorenza Caneva Italy 6 320 0.9× 148 0.5× 181 0.6× 204 1.2× 68 0.4× 9 600
Rodrigo Proto‐Siqueira Brazil 12 471 1.3× 161 0.6× 308 1.1× 92 0.5× 227 1.5× 15 889

Countries citing papers authored by Phillip E. Herrbrich

Since Specialization
Citations

This map shows the geographic impact of Phillip E. Herrbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip E. Herrbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip E. Herrbrich more than expected).

Fields of papers citing papers by Phillip E. Herrbrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip E. Herrbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip E. Herrbrich. The network helps show where Phillip E. Herrbrich may publish in the future.

Co-authorship network of co-authors of Phillip E. Herrbrich

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip E. Herrbrich. A scholar is included among the top collaborators of Phillip E. Herrbrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip E. Herrbrich. Phillip E. Herrbrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chen, Delphine L., Dong Zhou, Wenhua Chu, et al.. (2011). Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody. Nuclear Medicine and Biology. 39(1). 137–144. 20 indexed citations
2.
Chen, Delphine L., Dong Zhou, Wenhua Chu, et al.. (2009). Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Nuclear Medicine and Biology. 36(6). 651–658. 37 indexed citations
3.
Bauer, Gerhard, Mo A. Dao, Scott S. Case, et al.. (2008). In Vivo Biosafety Model to Assess the Risk of Adverse Events From Retroviral and Lentiviral Vectors. Molecular Therapy. 16(7). 1308–1315. 56 indexed citations
4.
Meyerrose, Todd E., Daniel A. De Ugarte, A. Alex Hofling, et al.. (2006). In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models. Stem Cells. 25(1). 220–227. 144 indexed citations
5.
Hess, David A., Louisa Wirthlin, Timothy P. Craft, et al.. (2005). Human CD34+Cells Mobilized by AMD3100 Demonstrate Enhanced NOD/SCID Repopulating Function Compared to CD34+ Cells Mobilized by Granulocyte Colony Stimulating Factor.. Blood. 106(11). 1962–1962. 4 indexed citations
6.
Hess, David A., Louisa Wirthlin, Timothy P. Craft, et al.. (2005). Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 107(5). 2162–2169. 226 indexed citations
7.
Hess, David A., Todd E. Meyerrose, Louisa Wirthlin, et al.. (2004). Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 104(6). 1648–1655. 267 indexed citations
8.
Hess, David A., Phillip E. Herrbrich, Louisa Wirthlin, Timothy P. Craft, & Jan A. Nolta. (2004). Isolation of Human CD34- Cells with High Aldehyde Dehydrogenase Activity Reveals a Novel Population with Hematopoietic Repopulating Potential.. Blood. 104(11). 3214–3214. 1 indexed citations
9.
Meyerrose, Todd E., Phillip E. Herrbrich, David A. Hess, & Jan A. Nolta. (2003). Immune-deficient mouse models for analysis of human stem cells. BioTechniques. 35(6). 1262–1272. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026